v3.25.2
Stockholders’ (Deficit) Equity - Additional Information (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 17, 2025
USD ($)
$ / shares
shares
Feb. 07, 2024
USD ($)
director
$ / shares
shares
Jun. 30, 2025
USD ($)
shares
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
shares
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Accumulated currency translation adjustments | $     $ 400   $ 400   $ 500
Total stock-based compensation expense | $     $ 2,423 $ 3,945 $ 5,201 $ 8,111  
Stock options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Stock option repricing program, minimum exercise price (in USD per share) $ 10.14            
Stock option repricing program, minimum exercise price reduced (in USD per share) $ 10.14            
Share-based payment award, options, eligible and outstanding, number | shares 1,700,000            
Total stock-based compensation expense | $ $ 700            
Private Placement              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of shares issued in transaction (in shares) | shares   10,500,000          
Share price (in USD per share)   $ 12.00          
Total gross proceeds | $   $ 127,800          
Private Placement | Two Directors              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of shares issued in transaction (in shares) | shares   23,000          
Share price (in USD per share)   $ 13.50          
Number of directors | director   2          
Private Placement | Pre-Funded Warrants              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Common stock issued upon exercise of warrants (in shares) | shares   75,000          
Share price (in USD per share)   $ 11.999          
Exercise price (in USD per share)   $ 0.001          
Beneficial ownership interest limitation (percent)     9.99%   9.99%    
Warrants exercised (in shares) | shares     0   0